Skip to Main Content

85

Views

0

CrossRef citations to date

0

Altmetric

ORIGINAL RESEARCH

A Post-Authorization Safety Surveillance Study to Report Clinical Experience with Purified Factor IX Concentrate in Pediatric Patients with Hemophilia B

Zoran Igrutinović1 Clinic of Pediatrics, Department of Hemato-Oncology, University Clinical Center of Kragujevac, Kragujevac, Serbia;2 Faculty of Medical Sciences, Department of Pediatrics, University of Kragujevac, Kragujevac, Serbia

https://orcid.org/0000-0002-9857-6475 View further author information

,

Hélène Louise Hooimeijer3 Pediatric Hematology, Beatrix Children’s Hospital, University Medical Center Groningen, Groningen, the NetherlandsView further author information

,

Karim Kentouche4 Klinik für Kinder- und Jugendmedizin, Universitätsklinikum Jena, Jena, DeutschlandView further author information

,

Jaco Botha5 Takeda Pharmaceuticals International AG, Zürich, SwitzerlandView further author information

,

Peter L Turecek6 Baxalta Innovations GmbH, Part of Takeda, Vienna, Austria

https://orcid.org/0000-0002-6161-1556 View further author information

,

Marta Kokot-Kierepa5 Takeda Pharmaceuticals International AG, Zürich, SwitzerlandView further author information

&

Hanna T Gazda7 Takeda Development Center Americas, Inc., Cambridge, MA, USACorrespondence[email protected]
View further author information